Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQReal EstateReit - RetailSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
2.53 → 2.53 EPS · FY ending Dec 31, 2027 · 7 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 8 to 7; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for REG yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain strong cash from operations near recent levels | A supporting condition in Regency Centers's published investment case. The stated target is >=150 million USD per quarter. | Intact | Cash from operations falls below $150 million per quarter | Cash from operations: $281.301M FY2026-Q2; GAAP. Published target: >=150 million USD per quarter. Target period is not explicitly aligned with this observation. Aug 3, 2026281,301,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
REG is a comparatively steady real estate business, with a dividend and operating growth at the center of its long-term thesis. The thesis is intact, but confidence is medium and recent execution is mixed: leasing and dividend progress are clear, while same-property growth and project execution need continued attention.
The valuation is about 16% above peers, and the evidence labels it justified, with a modest expectations gap. This suggests the market recognizes REG’s operating record without the evidence showing a highly fragile setup; valuation model confidence is medium.
Near term, same-property net operating income growth may remain steady but needs monitoring: it eased from 4.4% in the first quarter to 3.8% in the second, while full-year guidance was raised to 3.7% to 4.1%. Leasing was strong in the second quarter, the common dividend was maintained after an increase, and development projects continued to advance, though project execution remains mixed. The near-term miss risk is rated low, but recent earnings surprises have been erratic.
A key test is whether REG sustains its raised guidance; a reversal and cut would hurt management credibility as well as the operating outlook. Fed rate cuts could support rate-sensitive real estate, while weakness in sector peers could remove a recent sector tailwind.
For the next 1 to 3 years, the long-term thesis rests on sustained operating growth, leasing strength, and reliable guidance, with rates and sector conditions shaping the near-term backdrop. Current evidence supports an intact but not risk-free view. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Quarterly dividend at least $0.755 per share |
| It raised its dividend to $0.755 per share. |
| Intact |
| Dividend per share falls below $0.755 quarterly |
Dividend per share: $0.76 per share FY2026-Q2; GAAP. Published target: >=0.755 USD per share quarterly. Annual target cannot be compared with a quarterly or TTM observation. Aug 3, 20260.755 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Reaffirm 2026 earnings guidance at $4.83-$4.87 per share | Management reaffirmed 2026 earnings guidance near $4.87 per share. | Broken | EPS guidance falls below $4.83 per share for FY26 | Diluted EPS: $0.61 per share FY2026-Q2; GAAP. Published target: >=4.83 USD per share. Annual target cannot be compared with a quarterly or TTM observation. Aug 3, 20260.61 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Same property NOI growth between 3.25% and 3.75% | Same property NOI growth is expected between 3.25% and 3.75%. | Intact | Same Property NOI growth falls below 3.25% YoY in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$2.55 → $2.53 · observed estimates
$1.74B → $1.76B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $2.55 | $1,736,088,213 | 8 / 4 |
| 2026-07-25 | $2.52 | $1,685,711,780 | 7 / 4 |
| 2026-07-26 | $2.55 | $1,736,088,213 | 8 / 4 |
| 2026-07-27 | $2.52 | $1,685,711,780 | 7 / 4 |
| 2026-07-28 | $2.52 | $1,685,711,780 | 7 / 4 |
| 2026-07-29 | $2.52 | $1,685,711,780 | 7 / 4 |
| 2026-07-30 | $2.55 | $1,736,281,468 | 8 / 4 |
| 2026-07-31 | $2.52 | $1,685,711,780 | 7 / 4 |
| 2026-08-01 | $2.55 | $1,736,281,468 | 8 / 4 |
| 2026-08-02 | $2.52 | $1,685,711,780 | 7 / 4 |
| 2026-08-03 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-04 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-05 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-06 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-08 | $2.52 | $1,685,711,780 | 7 / 4 |
| 2026-08-09 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-10 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-12 | $2.52 | $1,692,344,530 | 7 / 4 |
| 2026-08-13 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-14 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-15 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-16 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-17 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-18 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-19 | $2.55 | $1,744,458,763 | 8 / 4 |
| 2026-08-20 | $2.61 | $1,741,380,105 | 8 / 4 |
| 2026-08-21 | $2.61 | $1,744,401,726 | 8 / 4 |
| 2026-08-22 | $2.61 | $1,744,401,726 | 8 / 4 |
| 2026-08-23 | $2.61 | $1,744,401,726 | 8 / 4 |
| 2026-08-24 | $2.61 | $1,744,401,726 | 8 / 4 |
| 2026-08-25 | $2.61 | $1,744,401,726 | 8 / 4 |
| 2026-08-26 | $2.61 | $1,744,401,726 | 8 / 4 |
| 2026-08-27 | $2.61 | $1,744,401,726 | 8 / 4 |
| 2026-08-28 | $2.61 | $1,744,401,726 | 8 / 4 |
| 2026-08-29 | $2.61 | $1,749,123,699 | 8 / 4 |
| 2026-08-30 | $2.61 | $1,749,123,699 | 8 / 4 |
| 2026-08-31 | $2.61 | $1,749,123,699 | 7 / 4 |
| 2026-09-01 | $2.55 | $1,755,930,635 | 7 / 4 |
| 2026-09-02 | $2.55 | $1,755,930,635 | 8 / 4 |
| 2026-09-03 | $2.55 | $1,755,946,208 | 8 / 4 |
| 2026-09-04 | $2.55 | $1,755,946,212 | 8 / 4 |
| 2026-09-05 | $2.55 | $1,755,946,212 | 8 / 4 |
| 2026-09-06 | $2.55 | $1,755,946,212 | 8 / 4 |
| 2026-09-07 | $2.55 | $1,755,946,212 | 8 / 4 |
| 2026-09-08 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-09 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-10 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-11 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-12 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-13 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-14 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-15 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-16 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-17 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-18 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-19 | $2.55 | $1,761,311,320 | 8 / 4 |
| 2026-09-20 | $2.55 | $1,761,294,186 | 8 / 4 |
| 2026-09-21 | $2.55 | $1,761,294,186 | 8 / 4 |
| 2026-09-22 | $2.55 | $1,761,294,186 | 8 / 4 |
| 2026-09-23 | $2.55 | $1,761,294,186 | 8 / 4 |
| 2026-09-24 | $2.55 | $1,761,294,186 | 8 / 4 |
| 2026-09-25 | $2.50 | $1,757,166,093 | 8 / 4 |
| 2026-09-26 | $2.50 | $1,755,506,129 | 8 / 4 |
| 2026-09-27 | $2.50 | $1,755,506,129 | 8 / 4 |
| 2026-09-28 | $2.50 | $1,755,506,129 | 8 / 4 |
| 2026-09-29 | $2.50 | $1,755,506,129 | 8 / 4 |
| 2026-09-30 | $2.50 | $1,755,506,129 | 8 / 4 |
| 2026-10-01 | $2.50 | $1,755,506,129 | 8 / 4 |
| 2026-10-02 | $2.50 | $1,755,506,129 | 8 / 4 |
| 2026-10-03 | $2.53 | $1,761,065,664 | 8 / 4 |
| 2026-10-04 | $2.53 | $1,761,065,664 | 8 / 4 |
| 2026-10-05 | $2.53 | $1,761,065,664 | 8 / 4 |
| 2026-10-06 | $2.53 | $1,761,081,236 | 8 / 4 |
| 2026-10-07 | $2.53 | $1,761,081,236 | 8 / 4 |
| 2026-10-08 | $2.53 | $1,761,081,236 | 8 / 4 |
| 2026-10-09 | $2.53 | $1,761,081,236 | 8 / 4 |
| 2026-10-10 | $2.53 | $1,761,081,236 | 8 / 4 |
| 2026-10-11 | $2.53 | $1,761,081,236 | 8 / 4 |
| 2026-10-12 | $2.53 | $1,761,081,236 | 8 / 4 |
| 2026-10-13 | $2.53 | $1,761,081,236 | 7 / 3 |
| 2026-10-14 | $2.53 | $1,761,081,236 | 7 / 3 |
| 2026-10-15 | $2.53 | $1,761,081,236 | 7 / 3 |
| 2026-10-16 | $2.53 | $1,761,081,236 | 7 / 3 |
| 2026-10-17 | $2.53 | $1,761,081,236 | 7 / 3 |
| 2026-10-18 | $2.53 | $1,761,081,236 | 7 / 3 |
| 2026-10-19 | $2.53 | $1,761,081,236 | 7 / 3 |
| 2026-10-20 | $2.53 | $1,761,081,236 | 7 / 3 |
| 2026-10-21 | $2.53 | $1,757,872,944 | 7 / 3 |
| 2026-10-22 | $2.53 | $1,757,872,944 | 7 / 3 |
| 2026-10-23 | $2.53 | $1,757,872,944 | 7 / 3 |
| 2026-10-24 | $2.53 | $1,757,872,944 | 7 / 3 |
| 2026-10-25 | $2.53 | $1,757,872,944 | 7 / 3 |
| 2026-10-26 | $2.53 | $1,757,872,944 | 7 / 3 |
| 2026-10-27 | $2.53 | $1,757,872,944 | 7 / 3 |
| 2026-10-28 | $2.53 | $1,757,872,944 | 7 / 3 |
| 2026-10-29 | $2.53 | $1,757,872,944 | 7 / 3 |
| 2026-10-30 | $2.53 | $1,757,872,947 | 7 / 3 |
| 2026-10-31 | $2.53 | $1,757,872,947 | 7 / 3 |
| 2026-11-01 | $2.53 | $1,757,872,947 | 7 / 3 |
| 2026-11-02 | $2.53 | $1,757,872,947 | 7 / 3 |
| 2026-11-03 | $2.53 | $1,757,872,947 | 7 / 3 |
| 2026-11-04 | $2.53 | $1,757,872,947 | 7 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 12 Buy / Strong Buy · 8 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 2 recorded
0 raises · 2 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.